L3Harris Technologies CapEx increased by 67.8% to $99.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 67.8%, from $59.00M to $99.00M. Over 2 years (FY 2021 to FY 2024), CapEx shows an upward trend with a 9.2% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $67.00M | $50.00M | $64.00M | $161.00M | $55.00M | $109.00M | $148.00M | $71.00M | $141.00M | $78.00M | $159.00M | $115.00M | $32.00M | $119.00M | $142.00M | $59.00M | $99.00M |
| QoQ Change | — | -25.4% | +28.0% | +151.6% | -65.8% | +98.2% | +35.8% | -52.0% | +98.6% | -44.7% | +103.8% | -27.7% | -72.2% | +271.9% | +19.3% | -58.5% | +67.8% |
| YoY Change | — | — | — | — | -17.9% | +118.0% | +131.3% | +29.1% | +29.4% | -47.3% | — | +62.0% | -77.3% | +52.6% | -10.7% | -48.7% | +67.8% |
| Segment | FY'21 | FY'22 |
|---|---|---|
| SAS | $155.00M | $133.00M |
| IMS | $69.00M | $45.00M |
| CS | $56.00M | $36.00M |
| Other non-reportable businesses | $4.00M | $0.00 |
| Total | $342.00M | — |
All segment values are derived from annual filings.
AR, CS, IMS, Other non-reportable businesses, SAS were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.